Mechanistically, STC2 regulates the expression of signal family transcription repressor 2 (SNAI2) and matrix metalloproteinases (MMPs) through the MAPK signaling pathway during the malignant transformation of GBM. The gene discussed is STC2; the disease is glioblastoma.